Cynthia Patton - Amgen Insider

AMGN -- USA Stock  

USD 185.01  1.06  0.58%

Senior Vice President Chief Compliance Officer

Ms. Cynthia M. Patton is the Senior Vice President, Chief Compliance Officer of Amgen Inc
Age: 54  President Since 2012      
805-447-1000  http://www.amgen.com
Patton joined the Company in 2005. From July 2005 to September 2010, Ms. Patton was Associate General Counsel. From September 2010 to October 2012, Ms. Patton was Vice President, Law. Previously, Ms. Patton served as Senior Vice President, General Counsel and Secretary of SCAN Health Plan from 1999 to 2005.

Cynthia Patton Latest Insider Activity

Cynthia Patton over three months ago via Macroaxis 
Payment of 132 shares by Cynthia Patton of Amgen subject to Rule 16b-3
Cynthia Patton over six months ago via Macroaxis 
Amgen exotic insider transaction detected
Cynthia Patton over a year ago via Macroaxis 
Amgen exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 8.84 % which means that it generated profit of $8.84 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 9.59 % meaning that it created $9.59 on every $100 dollars invested by stockholders.
The company currently holds 35.54 B in liabilities with Debt to Equity (D/E) ratio of 227.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen has Current Ratio of 3.8 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Michael RousseauAbbott Laboratories
2017
Jonathon KellermanAllergan plc
2014
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
Meredith FischerMallinckrodt Public Limited Com
2016
David RicksEli Lilly and Company
2017
Alfonso ZuluetaEli Lilly and Company
2017
Michael HolstonMerck Co
2015
Carrie NicholEndo International plc
2018
Paul SilvaVertex Pharmaceuticals Incorpor
2011
Francis CussBristol Myers Squibb Company
2013
Adam SchechterMerck Co
2010
Julie GerberdingMerck Co
2016
Myles ONeillEli Lilly and Company
2018
Terrance CarlsonMallinckrodt Public Limited Com
2015
John HertiaBio Rad Laboratories
2014
Brian LortieEndo International plc
N/A
Anne NielsenBristol Myers Squibb Company
2013
Ian SmithVertex Pharmaceuticals Incorpor
2017
Jaime ContrerasAbbott Laboratories
2013
Charles FoltzAbbott Laboratories
2013
Deepak NathAbbott Laboratories
2015

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people.Amgen (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Amgen Leadership Team

Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance Indicators

Current Sentiment - AMGN

Amgen Investor Sentiment
Majority of Macroaxis users are presently bullish on Amgen. What is your sentiment towards investing in Amgen? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Amgen and IQVIA Holdings. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.